Feasability of home spirometry in patients with Interstitial lung disease (ILD) during the COVID-19 pandemic

C. Ruggiero (Oxford, United Kingdom), A. Achaiah (Oxford, United Kingdom), V. Nathwani (Oxford, United Kingdom), E. Fraser (Oxford, United Kingdom), R. Hoyles (Oxford, United Kingdom), P. Saunders (Oxford, United Kingdom)

Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Session: Biomarkers and e-health in idiopathic interstitial pneumonia
Session type: E-poster
Number: 396

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Ruggiero (Oxford, United Kingdom), A. Achaiah (Oxford, United Kingdom), V. Nathwani (Oxford, United Kingdom), E. Fraser (Oxford, United Kingdom), R. Hoyles (Oxford, United Kingdom), P. Saunders (Oxford, United Kingdom). Feasability of home spirometry in patients with Interstitial lung disease (ILD) during the COVID-19 pandemic. 396

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Exercise training in patients with interstitial lung disease (ILD): Can reponders be distinguished from non-responders
Source: International Congress 2015 – Effects of rehabilitation, exercise, physical activity, hospitalisation and surgery on different conditions
Year: 2015

Effects of pulmonary rehabilitation in patients with interstitial lung disease (ILD)
Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation
Year: 2009


Pulmonary rehabilitation (PR) exercise tolerance improvement: Differences between interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions
Year: 2013


Effects of pulmonary rehabilitation in patients with severe COPD in comparison to patients with severe interstitial lung disease
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013


Interstitial lung disease (ILD) and multicompartment assessment of CTD: where should the respiratory physician begin?
Source: Virtual Congress 2020 – Rheumatology: understanding connective tissue disease in patients with interstitial lung disease
Year: 2020


Benefits of pulmonary rehabilitation (PR) in patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) having the same dyspnoea severity
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018

Novel lung function tests in patients with interstitial lung disease (ILD)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016

Temporal variations of oscillometric reactance in COPD and ILD
Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles
Year: 2015

Underutilization of spirometry in the hospital diagnosis of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008

Nasal high-Flow (NHF) improves ventilation in patients with interstitial lung disease (ILD)
Source: International Congress 2019 – Hot topics in noninvasive ventilation
Year: 2019

Pulmonary rehabilitation (PR) outcomes in chronic obstructive pulmonary disease (COPD) compared with interstitial lung disease (ILD)
Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD
Year: 2011

Efficacy of pulmonary rehabilitation in patients with interstitial lung disease
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012


Differing clinical courses of IPF at an acute district general hospital
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013


Desquamative interstitial pneumonia: Follow-up of 17 patients
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013


Comparison of efficacy of respiratory rehabilitation in patients with COPD and interstitial lung disease
Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD
Year: 2011

Delay in diagnosis of interstitial lung diseases (ILD)
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


Whole lung lavage therapy (WLL) of pulmonary alveolar proteinosis (PAP): A global survey of current practices and procedures
Source: International Congress 2016 – Orphan diseases I
Year: 2016

Survival rates after a rehabilitation program in patients with interstitial lung disease
Source: International Congress 2014 – Physiotherapy and physical activity in respiratory conditions
Year: 2014

The value of a specialist nurse-lead interstitial lung disease clinic, patients’ views
Source: International Congress 2015 – Kaleidoscope of nursing research
Year: 2015


Palliative and end-of-life care for patients with respiratory disease
Source: Eur Respir Mon; 2009: 43:327–353
Year: 2009